Table 1. Patient's baseline characteristics.

	No AS	AS	p
	N = 73	N = 241
Age	70±12	77±10	0.001
Gender (male), n (%)	47 (64.38)	95 (39.42)	<0.001
Hypertension n (%)	48 (65.75)	194(80.50)	0.011
Diabetes mellitus n (%)	22 (30.14)	84 (34.85)	0.48
Hyperlipidemia n (%)	56 (76.71)	177 (73.44)	0.65
Smoker n (%)	6 (8.22)	34 (14.11)	0.23
Coronary artery disease n (%)	33 (45.21)	106 (43.98)	0.89
Aspirin n (%)	38 (52.05	117 (48.55)	0.7
Beta blockers n (%)	36 (49.32)	158 (65.56)	0.014
ACEI n (%)	31(42.47)	123 (51.04)	0.23
Statin n (%)	48 (65.75)	169 (70.12)	0.47
Furosamide n (%)	7 (9.59)	46 (19.09)	0.07
Hemoglobin (g/dL)	13.6±1.39	12.32±1.64	0.001
White blood cells (K/ul)	7.3±2.02	7.49±1.92	0.45
Platelets (K/ul)	217±80	218.01±77.25	0.9
Creatinine (mg/ dL)	0.96±0.26	1.00±.34	0.43
Total cholesterol (mg/ dL)	164.25±38	167.28±39.27	0.55
LDL cholesterol (mg/ dL)	92.94±31	94.58±31.75	0.72
Triglycerides (mg/ dL)	129.39±63.5	125.23±57.61	0.62
HDL cholesterol(mg/ dL)	50.19±15	50.87±14.51	0.76
Left ventricular end diastolic diameter (mm)	45.66±5.84	45.60±5.64	0.94
Left ventricular end systolic diameter (mm)	27.63±5.82	27.01±5.20	0.57
Left ventricular ejection fraction (%)	55.11±6.43	55.31±7.00	0.84
Left ventricular mass (gr)	182.78±48	222.88±60.48	<0.001
EPCs (cells/μl)	2.64 (1.59–4.94)	4.08 (1.39–7.6)	0.017

ACEI-angiotensin converting enzyme inhibitor